| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Teyi Pharmaceutical Group Co.Ltd (SHE: 002728)
002728 Technical Analysis
5
| As on 17th Nov 2025 002728 STOCK Price closed @ 14.17 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.29 & Strong Buy for SHORT-TERM with Stoploss of 8.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002728STOCK Price
| Open | 14.60 | Change | Price | % |
| High | 14.80 | 1 Day | -1.04 | -6.84 |
| Low | 13.88 | 1 Week | 3.01 | 26.97 |
| Close | 14.17 | 1 Month | 5.64 | 66.12 |
| Volume | 127725921 | 1 Year | 4.64 | 48.69 |
| 52 Week High 13.83 | 52 Week Low 6.87 | ||||
SHE China Most Active Stocks
| 300058 | 8.69 | 12.42% |
| 000564 | 2.84 | 1.07% |
| 000981 | 3.53 | 0.57% |
| 002506 | 3.14 | -2.48% |
| 000620 | 3.83 | 10.06% |
| 000572 | 10.94 | 0.00% |
| 002426 | 4.06 | 7.41% |
| 002146 | 1.88 | -3.59% |
| 002131 | 5.09 | 4.73% |
| 000725 | 3.96 | -1.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002728 Daily Charts |
002728 Intraday Charts |
Whats New @ Bazaartrend |
002728 Free Analysis |
|
|
002728 Important Levels Intraday
| RESISTANCE | 15.94 |
| RESISTANCE | 15.37 |
| RESISTANCE | 15.02 |
| RESISTANCE | 14.67 |
| SUPPORT | 13.67 |
| SUPPORT | 13.32 |
| SUPPORT | 12.97 |
| SUPPORT | 12.40 |
002728 Forecast November 2025
| 4th UP Forecast | 17.04 |
| 3rd UP Forecast | 16.12 |
| 2nd UP Forecast | 15.55 |
| 1st UP Forecast | 14.98 |
| 1st DOWN Forecast | 13.36 |
| 2nd DOWN Forecast | 12.79 |
| 3rd DOWN Forecast | 12.22 |
| 4th DOWN Forecast | 11.3 |
002728 Weekly Forecast
| 4th UP Forecast | 15.38 |
| 3rd UP Forecast | 14.99 |
| 2nd UP Forecast | 14.75 |
| 1st UP Forecast | 14.51 |
| 1st DOWN Forecast | 13.83 |
| 2nd DOWN Forecast | 13.59 |
| 3rd DOWN Forecast | 13.35 |
| 4th DOWN Forecast | 12.96 |
002728 Forecast2025
| 4th UP Forecast | 30.4 |
| 3rd UP Forecast | 25.19 |
| 2nd UP Forecast | 21.98 |
| 1st UP Forecast | 18.76 |
| 1st DOWN Forecast | 9.58 |
| 2nd DOWN Forecast | 6.36 |
| 3rd DOWN Forecast | 3.15 |
| 4th DOWN Forecast | -2.06 |
Teyi Pharmaceutical Group Co.Ltd ( SHE China Symbol : 002728 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002728 Business Profile
Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, strontium and tannic acid, and zinc sulfate. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China. Address: Beikeng Industrial Park, Taishan, China, 529200
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service